EGF receptor (epidermal growth factor)
undergoes a partial gene deletion to generate the ligand-dependent ErbB oncogene that is associated w/ a form of leukemia distinguished by proliferation of immature red blood cells Erythroblastosis (where first discovered) and in breast cancers